These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16097190)

  • 1. Drug testing goes offshore.
    Lustgarten A
    Fortune; 2005 Aug; 152(3):66-70, 72. PubMed ID: 16097190
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical and scientific implications of the globalization of clinical research.
    Andrews CA
    N Engl J Med; 2009 Jun; 360(26):2793; author reply 2793. PubMed ID: 19557890
    [No Abstract]   [Full Text] [Related]  

  • 3. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
    Farrell K
    J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 5. More Chinese get free drugs in clinical trials.
    Berton E
    Wall St J (East Ed); 2006 Feb; ():B1, B8. PubMed ID: 16528877
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement?
    Ballantyne A
    Dev World Bioeth; 2008 Dec; 8(3):178-91. PubMed ID: 19046255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CQ sources/bibliography. Cambridge Quarterly of Healthcare Ethics.
    Anton B
    Camb Q Healthc Ethics; 2009 Apr; 18(2):155-8. PubMed ID: 19263598
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical considerations for clinical photography in the global South.
    Macintosh T
    Dev World Bioeth; 2006 May; 6(2):81-8. PubMed ID: 16594971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research with vulnerable participants.
    Lo B
    J Clin Ethics; 2004; 15(1):55-60. PubMed ID: 15202359
    [No Abstract]   [Full Text] [Related]  

  • 10. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
    Miossec M; Miossec P
    Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
    [No Abstract]   [Full Text] [Related]  

  • 11. Looking abroad: clinical drug trials.
    Hathaway CR; Manthei JR; Haas JB; Scherer CA
    Food Drug Law J; 2008; 63(3):673-81. PubMed ID: 19031667
    [No Abstract]   [Full Text] [Related]  

  • 12. Testing medications in children.
    Crawley FP; Kurz R; Nakamura H
    N Engl J Med; 2003 Feb; 348(8):763-4; author reply 763-4. PubMed ID: 12594329
    [No Abstract]   [Full Text] [Related]  

  • 13. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 14. Undue fear of inducements in research in developing countries.
    Arnason G; Van Niekerk A
    Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials or exploitation?
    Marino IR; Cirillo C
    Science; 2004 Oct; 306(5693):54-5. PubMed ID: 15459369
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
    Kinders R; Parchment RE; Ji J; Kummar S; Murgo AJ; Gutierrez M; Collins J; Rubinstein L; Pickeral O; Steinberg SM; Yang S; Hollingshead M; Chen A; Helman L; Wiltrout R; Simpson M; Tomaszewski JE; Doroshow JH
    Mol Interv; 2007 Dec; 7(6):325-34. PubMed ID: 18199854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Innovation in therapeutic materials and drugs: new ethics data].
    Chneiweiss H
    Med Sci (Paris); 2004 Mar; 20(3):259-60. PubMed ID: 15067563
    [No Abstract]   [Full Text] [Related]  

  • 18. Vulnerability: too vague and too broad?
    Schroeder D; Gefenas E
    Camb Q Healthc Ethics; 2009 Apr; 18(2):113-21. PubMed ID: 19250564
    [No Abstract]   [Full Text] [Related]  

  • 19. The Foreign Corrupt Practices Act and and clinical trials: a trap for the unwary.
    Harker DA; Miller CE
    Food Drug Law J; 2008; 63(2):509-23. PubMed ID: 18561475
    [No Abstract]   [Full Text] [Related]  

  • 20. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.